» Articles » PMID: 21448341

Transgenic Rice Expressing Amyloid β-peptide for Oral Immunization

Overview
Journal Int J Biol Sci
Specialty Biology
Date 2011 Mar 31
PMID 21448341
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Various vaccine therapies for Alzheimer's disease (AD) have been investigated. Here we report transgenic rice expressing amyloid β-peptide (Aβ). The Aβ42 gene fused with a green fluorescent protein gene was introduced into rice using the Agrobacterium method. When transgenic brown rice expressing Aβ was orally administered to mice, serum anti-Aβ antibody titers were elevated. The same results were observed when mice were fed boiled, transgenic brown rice. The results indicate that an edible vaccine against AD using rice may be feasible. A vaccine derived from rice would be far cheaper than existing medical vaccines.

Citing Articles

Current Advances of Plant-Based Vaccines for Neurodegenerative Diseases.

Bravo-Vazquez L, Mora-Hernandez E, Rodriguez A, Sahare P, Bandyopadhyay A, Duttaroy A Pharmaceutics. 2023; 15(2).

PMID: 36840033 PMC: 9963606. DOI: 10.3390/pharmaceutics15020711.


Emerging trends of edible vaccine therapy for combating human diseases especially COVID-19: Pros, cons, and future challenges.

Khalid F, Tahir R, Ellahi M, Amir N, Rizvi S, Hasnain A Phytother Res. 2022; 36(7):2746-2766.

PMID: 35499291 PMC: 9347755. DOI: 10.1002/ptr.7475.


Production of the herb Ruta chalepensis L. expressing amyloid β-GFP fusion protein.

Yoshida T, Watanabe Y, Ishiura S Proc Jpn Acad Ser B Phys Biol Sci. 2019; 95(6):295-302.

PMID: 31189782 PMC: 6751298. DOI: 10.2183/pjab.95.021.


Plant-based vaccines for Alzheimer's disease.

Ishiura S, Yoshida T Proc Jpn Acad Ser B Phys Biol Sci. 2019; 95(6):290-294.

PMID: 31189781 PMC: 6751297. DOI: 10.2183/pjab.95.020.


Production of BP178, a derivative of the synthetic antibacterial peptide BP100, in the rice seed endosperm.

Montesinos L, Bundo M, Badosa E, San Segundo B, Coca M, Montesinos E BMC Plant Biol. 2017; 17(1):63.

PMID: 28292258 PMC: 5351061. DOI: 10.1186/s12870-017-1011-9.


References
1.
Kim H, Cao Y, Kong F, Van Kampen K, Lewis T, Ma Z . Induction of a Th2 immune response by co-administration of recombinant adenovirus vectors encoding amyloid beta-protein and GM-CSF. Vaccine. 2005; 23(23):2977-86. DOI: 10.1016/j.vaccine.2004.12.015. View

2.
Janus C, Pearson J, McLaurin J, Mathews P, Jiang Y, Schmidt S . A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature. 2001; 408(6815):979-82. DOI: 10.1038/35050110. View

3.
Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T . Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature. 1999; 400(6740):173-7. DOI: 10.1038/22124. View

4.
Selkoe D . Alzheimer's disease: a central role for amyloid. J Neuropathol Exp Neurol. 1994; 53(5):438-47. DOI: 10.1097/00005072-199409000-00003. View

5.
Carlson G . A welcoming environment for amyloid plaques. Nat Neurosci. 2003; 6(4):328-30. DOI: 10.1038/nn0403-328. View